In Vitro and in Vivo Efficacy of SYL040012, a Novel siRNA Compound for Treatment of Glaucoma

Molecular Therapy - United States
doi 10.1038/mt.2013.216
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

In Vitro and in Vivo Efficacy of a Novel CD33-Targeted Thorium-227 Conjugate for the Treatment of Acute Myeloid Leukemia

Molecular Cancer Therapeutics
Cancer ResearchOncology
2016English

In Vitro and in Vivo Trypanocidal Effects of the Cyclopalladated Compound 7a, a Drug Candidate for Treatment of Chagas' Disease

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2010English

In Vivo Testing of a Novel Adjustable Glaucoma Drainage Device

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2014English

Author Correction: Evaluation of in Vitro and in Vivo Antibiotic Efficacy Against a Novel Bioluminescent Shigella Flexneri

Scientific Reports
Multidisciplinary
2020English

Anti-Hepatitis B Virus Activity of Α-DDB-Fncg, a Novel Nucleoside-Biphenyldicarboxylate Compound in Vitro and in Vivo

Journal of Pharmacological Sciences
Molecular MedicinePharmacology
2014English

In Vivo and in Vitro Efficacy of Amodiaquine Monotherapy for Treatment of Infection by Chloroquine-Resistant Plasmodium Vivax

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2008English

Fasting Cycles Potentiate the Efficacy of Gemcitabine Treatment in in Vitro and in Vivo Pancreatic Cancer Models

Oncotarget
Oncology
2015English

In Vitro and in Vivo Activities of Anti-Influenza Virus Compound T-705

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2002English

Correction: A Novel Compound NSC745885 Exerts an Anti-Tumor Effect on Tongue Cancer SAS Cells in Vitro and in Vivo

PLoS ONE
Multidisciplinary
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy